Literature DB >> 7955323

Development of vasoactive intestinal polypeptide neurons in the human suprachiasmatic nucleus in relation to birth and sex.

D F Swaab1, J N Zhou, T Ehlhart, M A Hofman.   

Abstract

The development of vasoactive intestinal polypeptide (VIP) neurons was determined in the human suprachiasmatic nucleus (SCN) of 43 subjects ranging from 27 weeks of gestation to 30 years of age using immunocytochemistry and morphometry. VIP neurons were first observed at 31 weeks of gestation in the ventrolateral part of the SCN. From 3 months postnatally onwards, VIP positive neurons were observed in some subjects in the centromedial part of the SCN. The centromedial type of VIP staining became a constant finding only at 19 years of age, at term the SCN was still very immature. Only in a few subjects some VIP neurons stained in the ventrolateral SCN and their number and nuclear diameter was small. Postnatally the number of VIP neurons increased gradually until around 3 years of age adult values were reached. After the age of 10 a clear sex difference in the number of VIP neurons was found: males having on average twice as many VIP neurons in the SCN as females. The adult VIP cell numbers in the SCN amounted only 35% of those found earlier for vasopressin. The present data do not support a particular role for VIP neurons in those rhythms that are already present in early development, e.g., of the temperature rhythm in prematures of around 30 weeks gestational age. Our observations in this and earlier papers as well as animal studies do suggest though a possible role for VIP neurons in the SCN in sexual dimorphic functions such as reproduction and sexual behavior.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7955323     DOI: 10.1016/0165-3806(94)90129-5

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  14 in total

Review 1.  The role of androgen receptors in the masculinization of brain and behavior: what we've learned from the testicular feminization mutation.

Authors:  Damian G Zuloaga; David A Puts; Cynthia L Jordan; S Marc Breedlove
Journal:  Horm Behav       Date:  2008-02-15       Impact factor: 3.587

2.  Sexual differentiation of the bed nucleus of the stria terminalis in humans may extend into adulthood.

Authors:  Wilson C J Chung; Geert J De Vries; Dick F Swaab
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 3.  Regulation of VIP gene expression in general. Human lung cancer cells in particular.

Authors:  A Davidson; T W Moody; I Gozes
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

Review 4.  The neuroendocrine control of the circadian system: adolescent chronotype.

Authors:  Megan Hastings Hagenauer; Theresa M Lee
Journal:  Front Neuroendocrinol       Date:  2012-05-23       Impact factor: 8.606

Review 5.  Development of the human hypothalamus.

Authors:  D F Swaab
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

6.  Circadian oscillations of neuropeptide expression in the human biological clock.

Authors:  M A Hofman
Journal:  J Comp Physiol A Neuroethol Sens Neural Behav Physiol       Date:  2003-09-12       Impact factor: 1.836

Review 7.  The effects of prenatal sex steroid hormones on sexual differentiation of the brain.

Authors:  Serkan Karaismailoğlu; Ayşen Erdem
Journal:  J Turk Ger Gynecol Assoc       Date:  2013-09-01

Review 8.  Sex differences in daily timekeeping and circadian clock circuits.

Authors:  Deborah A M Joye; Jennifer A Evans
Journal:  Semin Cell Dev Biol       Date:  2021-05-14       Impact factor: 7.499

Review 9.  Embryonic development of circadian clocks in the mammalian suprachiasmatic nuclei.

Authors:  Dominic Landgraf; Christiane E Koch; Henrik Oster
Journal:  Front Neuroanat       Date:  2014-12-01       Impact factor: 3.856

10.  Disruption of the Suprachiasmatic Nucleus in Fibroblast Growth Factor Signaling-Deficient Mice.

Authors:  Ann V Miller; Scott I Kavanaugh; Pei-San Tsai
Journal:  Front Endocrinol (Lausanne)       Date:  2016-02-08       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.